Table 1.
Baseline demographic characteristics of participants randomized to the yoga or control groups
| Characteristic | Yoga (n = 28) | Control (n = 16) |
|---|---|---|
| Age | ||
| Median (range) | 60 (33–74) | 56.5 (40–79.0) |
| Sex | ||
| Female | 27 (96.4%) | 15 (93.8%) |
| Male | 1 (3.6%) | 1 (6.3%) |
| Race | ||
| Missing | 1 (3.6) | 0 |
| Asian | 1 (3.6%) | 1 (6.3%) |
| Black or African American | 3 (10.7%) | 2 (12.5%) |
| White | 22 (78.6%) | 13 (81.3%) |
| Unknown or do not wish to report | 1 (3.6%) | 0 |
| Ethnicity | ||
| Missing | 1 (3.6) | 0 |
| Hispanic or Latino | 2 (7.1%) | 0 |
| Not Hispanic or Latino | 25 (89.3%) | 16 (100%) |
| Cancer type | ||
| Breast | 9 (32.1%) | 5 (31.3%) |
| Gastrointestinala | 7 (25%) | 3 (18.8%) |
| Gynecologicalb | 10 (35.7%) | 8 (50%) |
| Multiple | 2 (7.1%) | 0 |
| Cancer stage | ||
| Stage I | 4 (14.3%) | 2 (12.5%) |
| Stage II | 5 (17.9%) | 3 (18.8%) |
| Stage III | 10 (35.7%) | 9 (56.3%) |
| Metastatic | 8 (28.6%) | 2 (12.5%) |
| Unknown or missing | 1 (3.6%) | 0 |
| Chemotherapy type | ||
| Oxaliplatin | 7 (25%) | 3 (18.8%) |
| Taxanes | 9 (32.1%) | 4 (25%) |
| Taxanes and platinums | 12 (42.9%) | 9 (56.2%) |
| Time since last neurotoxic chemotherapy infusion | ||
| Median (range) | 242.5 (92–1423) | 249.5 (105–1708) |
| Risk factors for CIPN | ||
| No | 6 (21.4%) | 6 (37.5%) |
| Yesc | 22 (78.6%) | 10 (62.5%) |
| Number of minutes of yoga in the last 7 days at baseline | ||
| Median (range) | 0 (0–30) | 0 (no range) |
Note:
aGastrointestinal malignancies included colorectal, pancreas, gastroesophageal junction, small bowel, and extrahepatic bile duct
bGynecological malignancies included ovarian, endometrium, uterine, and fallopian tube
cThe most frequent potential risk factors for CIPN included anxiety, arthritis, depression, and obesity